Warning: The NCBI web site requires JavaScript to function. more...
Gene expression signatures of morphologically normal breast tissue identify basal-like tumors.
Finak G, Sadekova S, Pepin F, Hallett M, Meterissian S, Halwani F, Khetani K, Souleimanova M, Zabolotny B, Omeroglu A, Park M.
Breast Cancer Res. 2006;8(5):R58.
Related citations
Gene expression profiling of the tumor microenvironment during breast cancer progression.
Ma XJ, Dahiya S, Richardson E, Erlander M, Sgroi DC.
Breast Cancer Res. 2009;11(1):R7. Epub 2009 Feb 2.
Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis.
Turashvili G, Bouchal J, Baumforth K, Wei W, Dziechciarkova M, Ehrmann J, Klein J, Fridman E, Skarda J, Srovnal J, Hajduch M, Murray P, Kolar Z.
BMC Cancer. 2007 Mar 27;7:55.
Stromal gene expression predicts clinical outcome in breast cancer.
Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, Chen H, Omeroglu G, Meterissian S, Omeroglu A, Hallett M, Park M.
Nat Med. 2008 May;14(5):518-27. Epub 2008 Apr 27.
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures.
Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B, Desmedt C, Ignatiadis M, Sengstag T, Schütz F, Goldstein DR, Piccart M, Delorenzi M.
Breast Cancer Res. 2008;10(4):R65. Epub 2008 Jul 28.
In silico ascription of gene expression differences to tumor and stromal cells in a model to study impact on breast cancer outcome.
Myhre S, Mohammed H, Tramm T, Alsner J, Finak G, Park M, Overgaard J, Børresen-Dale AL, Frigessi A, Sørlie T.
PLoS One. 2010 Nov 19;5(11):e14002.
The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types.
Iacobuzio-Donahue CA, Argani P, Hempen PM, Jones J, Kern SE.
Cancer Res. 2002 Sep 15;62(18):5351-7.
Genome-wide transcriptomic profiling of microdissected human breast tissue reveals differential expression of KIT (c-Kit, CD117) and oestrogen receptor-alpha (ERalpha) in response to therapeutic radiation.
Westbury CB, Reis-Filho JS, Dexter T, Mahler-Araujo B, Fenwick K, Iravani M, Grigoriadis A, Parry S, Robertson D, Mackay A, Ashworth A, Yarnold JR, Isacke CM.
J Pathol. 2009 Sep;219(1):131-40.
A stromal gene signature associated with inflammatory breast cancer.
Boersma BJ, Reimers M, Yi M, Ludwig JA, Luke BT, Stephens RM, Yfantis HG, Lee DH, Weinstein JN, Ambs S.
Int J Cancer. 2008 Mar 15;122(6):1324-32.
Tumor stroma is the predominant uPA-, uPAR-, PAI-1-expressing tissue in human breast cancer: prognostic impact.
Hildenbrand R, Schaaf A, Dorn-Beineke A, Allgayer H, Sütterlin M, Marx A, Stroebel P.
Histol Histopathol. 2009 Jul;24(7):869-77.
Gene expression profiles of the fibroblasts from breast tumors and normal tissue compared with the tumor expression profiles.
Hussain SS, Qattan AT, Nirmal MS, Al-Malik OA, Al-Tweigeri TA, Tulba AM, Bin Amer SM.
Saudi Med J. 2006 Apr;27(4):463-9. Erratum in: Saudi Med J. 2006 Aug;27(8):1275.
Laser microdissection and microarray analysis of breast tumors reveal ER-alpha related genes and pathways.
Yang F, Foekens JA, Yu J, Sieuwerts AM, Timmermans M, Klijn JG, Atkins D, Wang Y, Jiang Y.
Oncogene. 2006 Mar 2;25(9):1413-9.
A SAGE (serial analysis of gene expression) view of breast tumor progression.
Porter DA, Krop IE, Nasser S, Sgroi D, Kaelin CM, Marks JR, Riggins G, Polyak K.
Cancer Res. 2001 Aug 1;61(15):5697-702.
The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R, Schaaf A.
Int J Oncol. 2009 Jan;34(1):15-23.
Microdissection and SAGE as a combined tool to reveal gene expression in ductal carcinoma in situ of the breast.
Verlinden I, Janssens J, Raus J, Michiels L.
Mol Carcinog. 2004 Dec;41(4):197-206.
Breaking down barriers: the importance of the stromal microenvironment in acquiring invasiveness in young women's breast cancer.
Schedin P, Borges V.
Breast Cancer Res. 2009;11(2):102. Epub 2009 Mar 26.
Identification of genes with altered expression in medullary breast cancer vs. ductal breast cancer and normal breast epithelia.
Gjerstorff MF, Benoit VM, Laenkholm AV, Nielsen O, Johansen LE, Ditzel HJ.
Int J Oncol. 2006 Jun;28(6):1327-35.
Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.
Kao J, Salari K, Bocanegra M, Choi YL, Girard L, Gandhi J, Kwei KA, Hernandez-Boussard T, Wang P, Gazdar AF, Minna JD, Pollack JR.
PLoS One. 2009 Jul 3;4(7):e6146.
Genomic patterns of allelic imbalance in disease free tissue adjacent to primary breast carcinomas.
Ellsworth DL, Ellsworth RE, Love B, Deyarmin B, Lubert SM, Mittal V, Shriver CD.
Breast Cancer Res Treat. 2004 Nov;88(2):131-9.
Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.
González LO, Corte MD, Junquera S, González-Fernández R, del Casar JM, García C, Andicoechea A, Vázquez J, Pérez-Fernández R, Vizoso FJ.
Hum Pathol. 2009 Sep;40(9):1224-33. Epub 2009 May 12.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on